GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055260) for “FIXED DOSE COMBINATION OF ANTI-FUCOSYL-GM1 ANTIBODY AND ANTI-PD-1 ANTIBODY AND USES THEREOF”. With publication no. WO/2026/107143, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....